CASI - CASI Pharmaceuticals: 2-Year Price Lows Make For Intriguing Risk-On Buy
Investment Thesis
CASI Pharmaceuticals (Casi) (CASI) is currently rated a "strong buy" by analysts who have set a consensus price target of $3.5. The stock currently trades at $1.67 after shedding 49% of its value since mid-January. Casi's share price has been volatile in the past (a good sign), but the current price represents a near 2-year low.
Casi Pharmaceuticals 1-year share price performance. Source: TradingView
I believe Casi represents an interesting investment proposition. The promise of its portfolio (which focuses on some of the more innovative and breakthrough aspects of oncological treatment) and proven